계명대학교 의학도서관 Repository

Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.

Metadata Downloads
Author(s)
Ju Yup LeeKyung Sik ParkHyun-Gyo LeeWon-Ki BaekKwang Bum ChoYoo Jin LeeYoon Suk LeeSeung-Wan Ryu
Keimyung Author(s)
Lee, Ju YupPark, Kyung SikBaek, Won KiCho, Kwang BumLee, Yoo JinLee, Yoon SukRyu, Seung Wan
Department
Dept. of Internal Medicine (내과학)
Dept. of Microbiology (미생물학)
Dept. of Surgery (외과학)
Institute for Cancer Research (암연구소)
Journal Title
Clinical and Experimental Medicine
Issued Date
2017
Volume
17
Issue
3
Keyword
BiomarkerHelicobacter pyloriPepsinogenTrefoil factor 3Gastric cancer
Abstract
Emerging data show that serum trefoil factor 3 (TFF3) alone and combined with the serum pepsinogen (PG) test can increase the diagnostic yield of gastric cancer. We aimed to evaluate the diagnostic value of serum TFF3 for the screening of gastric cancer in Korean patients, especially for the screening of the diffuse type of gastric cancer, and compared TFF3 to the serum PG test. We enrolled 25 healthy controls and 79 subjects with gastric cancer who underwent endoscopic resection or surgery from June 2006 to June 2015. Data about age, sex, histological type according to the Lauren classification, stage of gastric cancer, and status of H. pylori were collected. Serum levels of PG I and PG II were measured by the latex-enhanced turbidimetric immunoassay, and serum TFF3 levels were measured by enzyme-linked immunosorbent assay. The optimal cutoff value of serum TFF3 was ≥8.9 ng/mL to diagnose gastric cancer, with 73.4 % sensitivity and 92.0 % specificity, which were higher than those of the serum PG I/II ratio, with 69.6 % sensitivity and 68.0 % specificity. The optimal sensitivity and specificity of serum TFF3 for the diagnosis of diffuse-type gastric cancer were 68.0 and 92.0 %, respectively, which were lower than those for the diagnosis of intestinal-type gastric cancer (75.6 and 100 %, respectively). Serum TFF3 is a more stable and useful marker than the serum PG test for the screening of gastric cancer in Korean patients. Serum TFF3 showed good diagnostic power in detecting both intestinal- and diffuse-type gastric cancer although it showed decreased power in diffuse type.
Keimyung Author(s)(Kor)
이주엽
박경식
백원기
조광범
이유진
이윤석
류승완
Publisher
School of Medicine
Citation
Ju Yup Lee et al. (2017). Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer. Clinical and Experimental Medicine, 17(3), 403–410. doi: 10.1007/s10238-016-0426-1
Type
Article
ISSN
1591-8890
Source
https://link.springer.com/article/10.1007%2Fs10238-016-0426-1
DOI
10.1007/s10238-016-0426-1
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/32737
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
1. School of Medicine (의과대학) > Dept. of Microbiology (미생물학)
1. School of Medicine (의과대학) > Dept. of Surgery (외과학)
3. Research Institutues (연구소) > Institute for Cancer Research (암연구소)
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.